Nijhawan Pardeep Insider Trading Activity

Average Profitability
7.13%
Insider Buys Quantity
6
Insider Buys Sum
$90,322.20
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Nijhawan Pardeep

According to the SEC Form 4 filings, Nijhawan Pardeep, being in a position of

  1. Chief Executive Officer at Edesa Biotech, Inc.,
    оver the last 12 months, has bought 83571 share for $223,315, and sold 0 shares,
    over all time since 2020-03-17, has bought 106571 share for $313,637, and sold 0 shares.

Biography of Nijhawan Pardeep

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$223,3156100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-03-05PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
10,000
0.1266%
$3.90$39,000+57.06%
2026-03-04PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
10,000
0.1194%
$4.26$42,560+32.55%
2026-03-03PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
10,000
0.1907%
$3.63$36,300+30%
2026-03-02PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
3,000
0.0342%
$2.09$6,280+147.81%
2026-02-27PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
30,000
0.3632%
$2.22$66,696+156.82%
2026-02-26PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
20,571
0.251%
$1.58$32,480+264.52%
2024-03-25PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
5,000
0.1509%
$4.00$20,000+1.55%
2021-03-25PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
3,000
0.0263%
$5.25$15,750+7.18%
2021-03-24PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
5,000
0.0452%
$5.16$25,800+12.65%
2020-05-26PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
3,000
0.0328%
$2.98$8,939+84.09%
2020-03-29PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
2,000
0.0554%
$5.23$10,460+145.89%
2020-03-17PurchaseEdesa Biotech, Inc.
EDSA
Chief Executive Officer
5,000
0.0609%
$1.87$9,373+203.69%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.